Akebia Therapeutics Inc
NASDAQ:AKBA

Watchlist Manager
Akebia Therapeutics Inc Logo
Akebia Therapeutics Inc
NASDAQ:AKBA
Watchlist
Price: 2.04 USD 1.49% Market Closed
Market Cap: 540.9m USD
Have any thoughts about
Akebia Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one AKBA stock under the Base Case scenario is 2.87 USD. Compared to the current market price of 2.04 USD, Akebia Therapeutics Inc is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AKBA Intrinsic Value
2.87 USD
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Akebia Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AKBA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AKBA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Akebia Therapeutics Inc.

Explain Valuation
Compare AKBA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AKBA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Akebia Therapeutics Inc

Current Assets 234.7m
Cash & Short-Term Investments 137.3m
Receivables 72.8m
Other Current Assets 24.5m
Non-Current Assets 110.9m
PP&E 7.7m
Intangibles 59m
Other Non-Current Assets 44.2m
Current Liabilities 118.7m
Accounts Payable 11.6m
Accrued Liabilities 91.6m
Other Current Liabilities 15.5m
Non-Current Liabilities 197.7m
Long-Term Debt 177.4m
Other Non-Current Liabilities 20.2m
Efficiency

Free Cash Flow Analysis
Akebia Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Akebia Therapeutics Inc

Revenue
203.7m USD
Cost of Revenue
-34.2m USD
Gross Profit
169.5m USD
Operating Expenses
-165.5m USD
Operating Income
4m USD
Other Expenses
-40.5m USD
Net Income
-36.5m USD
Fundamental Scores

AKBA Profitability Score
Profitability Due Diligence

Akebia Therapeutics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

54/100
Profitability
Score

Akebia Therapeutics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

AKBA Solvency Score
Solvency Due Diligence

Akebia Therapeutics Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Positive Net Debt
Long-Term Solvency
High D/E
25/100
Solvency
Score

Akebia Therapeutics Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AKBA Price Targets Summary
Akebia Therapeutics Inc

Wall Street analysts forecast AKBA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AKBA is 7.55 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
197% Upside
Average
Price Target
7.55 USD
270% Upside
Highest
Price Target
10.5 USD
415% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Akebia Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AKBA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AKBA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AKBA stock?

The intrinsic value of one AKBA stock under the Base Case scenario is 2.87 USD.

Is AKBA stock undervalued or overvalued?

Compared to the current market price of 2.04 USD, Akebia Therapeutics Inc is Undervalued by 29%.

Back to Top